Birth Control
7
1
3
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
14.3%
1 terminated out of 7 trials
66.7%
-19.8% vs benchmark
29%
2 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
International Active Surveillance Study: Native Estrogen Estetrol (E4) Safety Study
RCT Evaluating Standardized Counseling on Early Discontinuation for Irregular Bleeding in Nexplanon Users
Quick Start of Highly Effective Contraception
Effects of a Progestin on Frequent and/or Prolonged Bleeding With Nexplanon™
HER Salt Lake Initiative
The Effect of Birth Control Methods on Anti-Mullerian Hormone (AMH) Levels
Prostate Specific Antigen (PSA) and Acute Failure Modes Study of the PATH Woman's Condom and FC2 Female Condom